Balyasny Asset Management LLC Acadia Pharmaceuticals Inc Put Options Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
Put Options
2 transactions
Others Institutions Holding ACAD
# of Institutions
280Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$744 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$240 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$238 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$209 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$104 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.81B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...